| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.961 | 0.002 | 0.964 | Psychostimulant | 0.964 0.002 CID_15129 | CID_15129 | |
| 0.913 | 0.003 | 0.913 | Spasmolytic | 0.884 0.003 CID_15129 | ||
| 0.913 | 0.004 | 0.913 | Analgesic | 0.867 0.005 CID_15129 | ||
| 0.768 | 0.005 | 0.768 | Aldehyde oxidase inhibitor | 0.45 0.04 CID_15129 | ||
| 0.758 | 0.003 | 0.758 | Analgesic, opioid | 0.639 0.003 CID_15129 | ||
| 0.62 | 0.003 | 0.62 | Opioid mu receptor agonist | 0.467 0.003 CID_15129 | ||
| 0.62 | 0.004 | 0.62 | Opioid antagonist | 0.493 0.004 CID_15129 | ||
| 0.598 | 0.003 | 0.598 | Opioid mu receptor antagonist | 0.498 0.004 CID_15129 | ||
| 0.589 | 0.008 | 0.589 | Potassium channel (Voltage-sensitive) blocker | 0.403 0.026 CID_15129 | ||
| 0.563 | 0.003 | 0.563 | Opioid agonist | 0.366 0.004 CID_15129 | ||
| 0.57 | 0.018 | 0.754 | 5 Hydroxytryptamine release stimulant | 0.754 0.005 CID_15129 | CID_15129 | |
| 0.524 | 0.007 | 0.524 | P-glycoprotein inhibitor | 0.328 0.024 CID_15129 | ||
| 0.49 | 0.005 | 0.49 | Cholinergic antagonist | 0.349 0.01 CID_15129 | ||
| 0.469 | 0.005 | 0.469 | Acetylcholine antagonist | 0.313 0.013 CID_15129 | ||
| 0.53 | 0.076 | 0.53 | Antiinflammatory | 0.518 0.08 CID_15129 | ||
| 0.436 | 0.022 | 0.436 | HERG channel blocker | 0.217 0.081 CID_15129 | ||
| 0.41 | 0.021 | 0.41 | Potassium channel blocker | 0.273 0.056 CID_15129 | ||
| 0.387 | 0.007 | 0.387 | Anesthetic local | 0.253 0.019 CID_15129 | ||
| 0.384 | 0.03 | 0.384 | Hypoglycemic | 0.273 0.064 CID_15129 | ||
| 0.34 | 0.005 | 0.34 | Acetylcholine nicotinic antagonist | 0.258 0.009 CID_15129 | ||
| 0.38 | 0.086 | 0.38 | Histamine release inhibitor | 0.373 0.089 CID_15129 | ||
| 0.348 | 0.056 | 0.348 | Vasodilator, coronary | 0.314 0.077 CID_15129 | ||
| 0.307 | 0.077 | 0.307 | Immunostimulant | 0.232 0.104 CID_15129 | ||
| 0.278 | 0.052 | 0.278 | DNA synthesis inhibitor | 0.258 0.061 CID_15129 | ||
| 0.28 | 0.057 | 0.285 | 5 Hydroxytryptamine uptake stimulant | 0.285 0.054 CID_15129 | CID_15129 | |
| 0.338 | 0.126 | 0.343 | 5 Hydroxytryptamine release inhibitor | 0.343 0.122 CID_15129 | CID_15129 | |
| 0.349 | 0.139 | 0.63 | Apoptosis agonist | 0.63 0.043 CID_15129 | CID_15129 | |
| 0.225 | 0.019 | 0.225 | Acetylcholine muscarinic antagonist | 0.132 0.056 CID_15129 | ||
| 0.26 | 0.068 | 0.28 | Gastrin inhibitor | 0.28 0.048 CID_15129 | CID_15129 | |
| 0.254 | 0.067 | 0.254 | Vasodilator | 0.206 0.1 CID_15129 | ||
| 0.285 | 0.101 | 0.285 | Cholesterol antagonist | 0.237 0.135 CID_15129 | ||
| 0.28 | 0.1 | 0.28 | Apoptosis antagonist | |||
| 0.275 | 0.096 | 0.275 | Immunomodulator | |||
| 0.247 | 0.068 | 0.247 | Hypolipemic | 0.148 0.139 CID_15129 | ||
| 0.245 | 0.082 | 0.267 | Interleukin agonist | 0.267 0.067 CID_15129 | CID_15129 | |
| 0.167 | 0.011 | 0.167 | Neuronal nicotinic receptor antagonist | 0.129 0.015 CID_15129 | ||
| 0.18 | 0.025 | 0.18 | Microtubule formation inhibitor | 0.175 0.027 CID_15129 | ||
| 0.197 | 0.044 | 0.197 | Acetylcholine M1 receptor antagonist | 0.122 0.106 CID_15129 | ||
| 0.209 | 0.07 | 0.209 | Anesthetic general | 0.176 0.089 CID_15129 | ||
| 0.253 | 0.125 | 0.343 | Vasodilator, peripheral | 0.343 0.077 CID_15129 | CID_15129 | |
| 0.171 | 0.044 | 0.19 | Alpha-N-acetylglucosaminidase inhibitor | 0.19 0.037 CID_15129 | CID_15129 | |
| 0.179 | 0.055 | 0.179 | Arachidonic acid antagonist | 0.151 0.087 CID_15129 | ||
| 0.257 | 0.142 | 0.305 | Immunosuppressant | 0.305 0.112 CID_15129 | CID_15129 | |
| 0.179 | 0.065 | 0.179 | MAP kinase kinase 5 inhibitor | 0.166 0.096 CID_15129 | ||
| 0.119 | 0.012 | 0.119 | Elastase 1 inhibitor | 0.088 0.029 CID_15129 | ||
| 0.24 | 0.134 | 0.347 | Antithrombotic | 0.347 0.066 CID_15129 | CID_15129 | |
| 0.148 | 0.047 | 0.148 | Cathepsin H inhibitor | 0.13 0.064 CID_15129 | ||
| 0.148 | 0.047 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.139 0.077 CID_15129 | ||
| 0.107 | 0.013 | 0.131 | Neuraminidase inhibitor | 0.131 0.008 CID_15129 | CID_15129 | |
| 0.168 | 0.083 | 0.168 | Lipocortins synthesis antagonist | 0.155 0.098 CID_15129 | ||
| 0.146 | 0.062 | 0.146 | Calcium channel blocker | 0.111 0.099 CID_15129 | ||
| 0.119 | 0.035 | 0.119 | Calcium antagonist | 0.077 0.067 CID_15129 | ||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.113 0.061 CID_15129 | ||
| 0.204 | 0.128 | 0.211 | Tyrosine 3 hydroxylase inhibitor | 0.211 0.117 CID_15129 | CID_15129 | |
| 0.115 | 0.041 | 0.115 | Uric acid excretion stimulant | |||
| 0.143 | 0.075 | 0.155 | Adenylate cyclase stimulant | 0.155 0.055 CID_15129 | CID_15129 | |
| 0.084 | 0.02 | 0.084 | Cathepsin E inhibitor | 0.063 0.037 CID_15129 | ||
| 0.095 | 0.032 | 0.095 | Estrogen-related receptor beta agonist | 0.084 0.054 CID_15129 | ||
| 0.149 | 0.088 | 0.165 | Growth hormone agonist | 0.165 0.076 CID_15129 | CID_15129 | |
| 0.277 | 0.22 | 0.369 | Caspase 9 stimulant | 0.369 0.131 CID_15129 | CID_15129 | |
| 0.122 | 0.066 | 0.122 | Alkylator | 0.119 0.069 CID_15129 | ||
| 0.081 | 0.025 | 0.103 | Neuraminidase (influenza) inhibitor | 0.103 0.016 CID_15129 | CID_15129 | |
| 0.076 | 0.026 | 0.076 | Androgen agonist | |||
| 0.164 | 0.114 | 0.164 | Insulin sensitizer | 0.147 0.138 CID_15129 | ||
| 0.165 | 0.117 | 0.165 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.052 | 0.006 | 0.052 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.112 | 0.067 | 0.112 | Photosensitizer | |||
| 0.057 | 0.015 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 CID_15129 | CID_15129 | |
| 0.088 | 0.047 | 0.088 | Opioid kappa receptor antagonist | |||
| 0.119 | 0.079 | 0.119 | Cyclooxygenase 3 inhibitor | 0.117 0.081 CID_15129 | ||
| 0.063 | 0.025 | 0.063 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.047 CID_15129 | ||
| 0.076 | 0.038 | 0.076 | Opioid delta receptor antagonist | |||
| 0.051 | 0.014 | 0.051 | Squalene synthetase inhibitor | 0.043 0.017 CID_15129 | ||
| 0.095 | 0.061 | 0.095 | Prolactin inhibitor | |||
| 0.089 | 0.057 | 0.116 | Ornithine decarboxylase inhibitor | 0.116 0.029 CID_15129 | CID_15129 | |
| 0.101 | 0.068 | 0.101 | Toll-Like receptor 4 antagonist | |||
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.096 | 0.068 | 0.105 | Anabolic | 0.105 0.056 CID_15129 | CID_15129 | |
| 0.06 | 0.033 | 0.06 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.079 | 0.052 | 0.079 | Na+ K+ transporting ATPase inhibitor | |||
| 0.143 | 0.117 | 0.143 | Hepatoprotectant | 0.137 0.125 CID_15129 | ||
| 0.035 | 0.013 | 0.035 | Elastase 3B inhibitor | 0.034 0.015 CID_15129 | ||
| 0.035 | 0.013 | 0.035 | Elastase 3A inhibitor | 0.034 0.015 CID_15129 | ||
| 0.035 | 0.013 | 0.035 | Elastase 2B inhibitor | 0.034 0.015 CID_15129 | ||
| 0.049 | 0.029 | 0.049 | Microtubule stabilization | 0.046 0.034 CID_15129 | ||
| 0.068 | 0.049 | 0.068 | Exportin-1 inhibitor | |||
| 0.116 | 0.097 | 0.117 | Protein kinase stimulant | 0.117 0.096 CID_15129 | CID_15129 | |
| 0.087 | 0.069 | 0.088 | Glutamate release inhibitor | 0.088 0.068 CID_15129 | CID_15129 | |
| 0.026 | 0.012 | 0.026 | Elastase 2A inhibitor | 0.023 0.014 CID_15129 | ||
| 0.026 | 0.012 | 0.026 | Elastase 2 inhibitor | 0.023 0.014 CID_15129 | ||
| 0.093 | 0.08 | 0.093 | Adenylate kinase inhibitor | |||
| 0.107 | 0.094 | 0.107 | Toll-Like receptor 2 antagonist | 0.105 0.096 CID_15129 | ||
| 0.088 | 0.074 | 0.088 | Aminopeptidase B inhibitor | 0.088 0.074 CID_15129 | ||
| 0.06 | 0.047 | 0.078 | Caspase 9 inhibitor | 0.078 0.025 CID_15129 | CID_15129 | |
| 0.068 | 0.056 | 0.071 | Aminopeptidase I inhibitor | 0.071 0.052 CID_15129 | CID_15129 | |
| 0.056 | 0.044 | 0.056 | Lipocortins synthesis agonist | 0.054 0.051 CID_15129 | ||
| 0.2 | 0.188 | 0.226 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 CID_15129 | CID_15129 | |
| 0.08 | 0.069 | 0.135 | Transcription factor NF kappa B stimulant | 0.135 0.02 CID_15129 | CID_15129 | |
| 0.082 | 0.071 | 0.082 | Falcipain inhibitor | |||
| 0.026 | 0.016 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 CID_15129 | CID_15129 | |
| 0.05 | 0.042 | 0.05 | Acetyl-CoA transferase inhibitor | |||
| 0.078 | 0.072 | 0.078 | Falcipain 2 inhibitor | |||
| 0.03 | 0.024 | 0.03 | Caspase 2 inhibitor | |||
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_15129 | ||
| 0.065 | 0.065 | 0.092 | Glutamate dehydrogenase inhibitor | 0.092 0.035 CID_15129 | CID_15129 | |
| 0.044 | 0.046 | 0.05 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.036 CID_15129 | CID_15129 | |
| 0.047 | 0.05 | 0.049 | Vanilloid 2 antagonist | 0.049 0.046 CID_15129 | CID_15129 | |
| 0.171 | 0.178 | 0.22 | Transcription factor STAT3 inhibitor | 0.22 0.111 CID_15129 | CID_15129 | |
| 0.059 | 0.067 | 0.065 | Catalase inhibitor | 0.065 0.059 CID_15129 | CID_15129 | |
| 0.109 | 0.118 | 0.12 | Vanilloid 1 agonist | 0.12 0.088 CID_15129 | CID_15129 | |
| 0.082 | 0.094 | 0.106 | Expectorant | 0.106 0.062 CID_15129 | CID_15129 | |
| 0.053 | 0.068 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 CID_15129 | CID_15129 | |
| 0.158 | 0.174 | 0.189 | Peptidyltransferase inhibitor | 0.189 0.113 CID_15129 | CID_15129 | |
| 0.04 | 0.058 | 0.051 | Human rhinovirus A protease inhibitor | 0.051 0.042 CID_15129 | CID_15129 | |
| 0.065 | 0.083 | 0.069 | Vanilloid 4 agonist | 0.069 0.067 CID_15129 | CID_15129 | |
| 0.175 | 0.195 | 0.242 | Transcription factor NF kappa B inhibitor | 0.242 0.133 CID_15129 | CID_15129 | |
| 0.038 | 0.065 | 0.085 | Baculoviral IAP repeat-containing protein inhibitor | 0.085 0.004 CID_15129 | CID_15129 | |
| 0.026 | 0.063 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.033 CID_15129 | CID_15129 | |
| 0.079 | 0.12 | 0.112 | Proteasome inhibitor | 0.112 0.073 CID_15129 | CID_15129 | |
| 0.043 | 0.096 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.043 CID_15129 | CID_15129 | |
| 0.013 | 0.083 | 0.035 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.035 0.004 CID_15129 | CID_15129 | |
| 0.147 | 0.223 | 0.168 | Nitric-oxide synthase stimulant | 0.168 0.159 CID_15129 | CID_15129 | |
| 0.149 | 0.242 | 0.19 | Transcription factor STAT inhibitor | 0.19 0.153 CID_15129 | CID_15129 | |
| 0.005 | 0.11 | 0.016 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.016 0.003 CID_15129 | CID_15129 | |
| 0.109 | 0.246 | 0.166 | Neurotensin receptor agonist | 0.166 0.068 CID_15129 | CID_15129 | |
| 0.034 | 0.276 | 0.095 | Nitric-oxide synthase inhibitor | 0.095 0.068 CID_15129 | CID_15129 | |
| 0.12 | 0.511 | 0.266 | Calcium channel L-type activator | 0.266 0.188 CID_15129 | CID_15129 | |
| 0.084 | 0.488 | 0.233 | Caspase 3 stimulant | 0.233 0.128 CID_15129 | CID_15129 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |